Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis
Status:
Withdrawn
Trial end date:
2019-10-08
Target enrollment:
Participant gender:
Summary
This study is to evaluate non inferiority of Eurofarma budesonide nasal spray x referral
Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients
will receive Astrazeneca medication. There is no placebo group.